Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DKFP51
|
|||
| Drug Name |
Pabinafusp alfa
|
|||
| Drug Type |
Fusion protein
|
|||
| Indication | Mucopolysaccharidosis II [ICD-11: 5C56.31] | Phase 2/3 | [1] | |
| Company |
PCR Pharmaceuticals Hyogo, Japan Takeda
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II. Mol Ther. 2021 Feb 3;29(2):671-679. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.